Wednesday, Medtronic Inc. (MDT) announced the full U.S. market release of MASTERGRAFT Strip - a new, highly flexible ceramic scaffold intended for use in combination with a patient's own bone for fusing multiple levels of the posterolateral spine. MASTERGRAFT Strip was cleared by the U.S. Food and Drug Administration or FDA earlier this year and has been clinically evaluated by surgeons for a variety of bone grafting procedures with outstanding intraoperative performance.
MASTERGRAFT Strip provides surgeons with a bone grafting option that offers a continuous latticework for longer grafting procedures at the back of the spine, which are often performed when the spine loses stability or its natural shape. The product's broad geometric design maximizes bony surface area contact and allows for continuous bone growth over large bony gaps, the company said.
The product comes in unique lengths that eliminate the need to utilize multiple units of a synthetic product for a long fusion. The combination of these handling characteristics and the features common to all MASTERGRAFT Products provides surgeons with a synthetic graft that has all the necessary qualities of a scaffold for multi-level posterolateral fusion procedures.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.